Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azik Hoffman

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Israel Medical Association Journal : IMAJ|October 18, 2007
Bromine--the red cloud approachingIgor Makarovsky, Gal Markel, Azik Hoffman, et al.
Harefuah|April 28, 2007
[Cyanides--treatment beneath the shade of terror]Amir Krivoy, Arseny Finkelstein, Eran Rotman, et al.
Andrology|September 6, 2022
Varicocoele in adolescence and testicular cancer in young adulthoodGuy Verhovsky, Moshe Giladi, Dorit Tzur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program databaseRaj Satkunasivam, Christopher J D Wallis, James Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 TrialPaul Toren, Azik Hoffman, Keyue Ding, et al.
Urology|June 14, 2016
Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Georg Bjarnason, James Byrne, et al.
Clinical Genitourinary Cancer|January 24, 2024
Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder CancerZiv Savin, Roy Mano, Alon Lazarovich, et al.
Journal of Geriatric Oncology|September 16, 2023
11-item modified frailty index and outcomes after radical cystectomyZiv Savin, Ofer Yossepowitch, Alon Lazarovich, et al.
Journal of Personalized Medicine|March 25, 2022
Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy CandidatesBarak Rosenzweig, Rennen Haramaty, Tima Davidson, et al.
Journal of Personalized Medicine|June 24, 2022
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. <i>J. Pers. Med.</i> 2022, <i>12</i>, 410"Barak Rosenzweig, Rennen Haramaty, Tima Davidson, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Israel Medical Association Journal : IMAJ|October 18, 2007
Bromine--the red cloud approachingIgor Makarovsky, Gal Markel, Azik Hoffman, et al.
Harefuah|April 28, 2007
[Cyanides--treatment beneath the shade of terror]Amir Krivoy, Arseny Finkelstein, Eran Rotman, et al.
Andrology|September 6, 2022
Varicocoele in adolescence and testicular cancer in young adulthoodGuy Verhovsky, Moshe Giladi, Dorit Tzur, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2017
Perioperative outcomes following radical prostatectomy for patients with disseminated cancer: An analysis of the National Surgical Quality Improvement Program databaseRaj Satkunasivam, Christopher J D Wallis, James Byrne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 TrialPaul Toren, Azik Hoffman, Keyue Ding, et al.
Urology|June 14, 2016
Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program DatabaseChristopher J D Wallis, Georg Bjarnason, James Byrne, et al.
Clinical Genitourinary Cancer|January 24, 2024
Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder CancerZiv Savin, Roy Mano, Alon Lazarovich, et al.
Journal of Geriatric Oncology|September 16, 2023
11-item modified frailty index and outcomes after radical cystectomyZiv Savin, Ofer Yossepowitch, Alon Lazarovich, et al.
Journal of Personalized Medicine|March 25, 2022
Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy CandidatesBarak Rosenzweig, Rennen Haramaty, Tima Davidson, et al.
Journal of Personalized Medicine|June 24, 2022
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. <i>J. Pers. Med.</i> 2022, <i>12</i>, 410"Barak Rosenzweig, Rennen Haramaty, Tima Davidson, et al.
Pageof 4